tirzepatide 40mg — 40mg/vial Reference Standard Tirz- 40mg (Research Use Only)

Once administered, it binds to GLP-1 receptors throughout your body, triggering several physiological responses: Pancreatic effects : Stimulates insulin secretion when blood glucose levels are elevated and suppresses glucagon release, helping to normalize blood sugar Gastric effects : Slows gastric emptying, meaning food stays in your stomach longer, promoting feelings of fullness [1] [2] Central nervous system effects : Acts on appetite centers in the brain to reduce hunger and food cravings Cardiovascular benefits : Reduces the risk of major adverse cardiovascular events in adults with established cardiovascular disease and overweight/obesity (Wegovy) or type 2 diabetes (Ozempic) [5] [6] The medication has a long half-life of approximately one week, which allows for once-weekly subcutaneous injection

Its a dual-agonist, meaning it targets both GLP-1 and another hormone called GIP (glucose-dependent insulinotropic polypeptide)

Combs, J.P

The appropriate choice depends on individual metabolic needs, health status, and whether restoration of natural function or pharmaceutical intervention is the goal

Diabetes Care, 27(1), 281282